Search

everythinglearnresearchcommunity

for

Search:↓

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Negative views about alopecia worsen quality of life and increase anxiety and depression.

Patients were highly satisfied with shared medical appointments for hair loss treatment.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Higher inflammation markers are linked to more severe alopecia areata.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

Alopecia areata greatly affects the quality of life for children and their families.

A comprehensive approach is needed to accurately assess alopecia areata severity and guide treatment decisions.

Measuring bald patch size can help grade hair loss severity, with photograph-based evaluation being more reliable.

The questionnaire effectively measures men's perceived hair growth and can distinguish between different treatments and dosages.

Unmarried individuals and those with diabetes have a poorer quality of life with alopecia areata.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Alopecia areata may be linked to higher heart disease risk.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

First-episode psychosis patients have higher hair cortisol levels, indicating early stress response issues.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Greater concern about hair loss is linked to more severe hair loss and worse quality of life.

Hair loss may indicate higher risk of heart disease.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

Androgenetic alopecia significantly reduces quality of life in men.

Hair mass index is a precise way to measure hair loss in chemotherapy patients.

Women find hair loss more distressing than men and often underestimate it, needing more public awareness and professional support.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Adults with alopecia areata have a higher risk of mental health issues, especially women after COVID-19.